Find Court Cases > Go Back to List > Bagnola v. Smithkline Beecham Clinical Laboratories

Bagnola v. Smithkline Beecham Clinical Laboratories

Case Date: 08/23/2002
Court: 1st District Appellate
Docket No: 1-00-0224 Rel

n turn, was affirmed by this court. Rodriguez, 297 Ill. App. 3d at 922. The requirements for application of collateral estoppel have been satisfied. The issue decided in the prior adjudication is identical to that presented in the current action. For the reasons previously discussed, we conclude that the doctrine of collateral estoppel is applicable in the instant case and operates as a bar to plaintiff's spoliation claim.

CONCLUSION

Pursuant to the doctrines of res judicata and collateral estoppel, we find that the judgment in the first proceeding is conclusive to this cause of action and bars plaintiff from asserting the spoliation claim against the City and SBCL. Based on this finding, it is unnecessary to address plaintiff's other arguments. Accordingly, we affirm the trial court's entry of summary judgment on behalf of SBCL and the City.

Affirmed.

COHEN, P.J., and McNULTY, J., concur.